FDA approves migraine nasal spray

被引：0

|

作者：

不详

机构：

来源：

NURSE PRACTITIONER | 2023年 / 48卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

引用

收藏

页码：48 / 48

页数：1

相关论文

共 50 条

[1] FDA Approves First Epinephrine Nasal Spray
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2024, 124 (12) : 17 - 17
[2] FDA Approves Easy-to-use Naloxone Nasal Spray
不详
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2016, 30 (01) : 77 - +
[3] FDA approves first naloxone nasal spray for opioid overdose
Reactions Weekly, 2015, 1580 (1) : 1 - 1
[4] FDA approves RiVive naloxone nasal spray for opioid overdose
Reactions Weekly, 2023, 1969 (1) : 2 - 2
[5] FDA approves naloxone 8mg nasal spray for opioid overdose
Reactions Weekly, 2021, 1855 (1) : 3 - 3
[6] FDA Approves Nalmefene, a Longer-Lasting Opioid Reversal Nasal Spray
Harris, Emily
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (23): : 2012 - 2012
[7] FDA approves first OTC naloxone nasal spray for reversal of opioid overdose
Reactions Weekly, 2023, 1952 (1) : 3 - 3
[8] FDA approves first migraine preventive
Brainard, Jeffrey
SCIENCE, 2018, 360 (6391) : 836 - 836
[9] FDA Approves Botox for Chronic Migraine
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (01) : 104 - 104
[10] FDA approves new migraine treatment
不详
NURSE PRACTITIONER, 2020, 45 (02): : 56 - 56

← 1 2 3 4 5 →